Home › Compare › VRCV vs JNJ

VRCV vs JNJ: Dividend Comparison 2026

VRCV yields 200000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRCV wins by $4.911780474428384e+29M in total portfolio value
10 years
VRCV
VRCV
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full VRCV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VRCV vs JNJ

📍 VRCV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRCVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRCV + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VRCV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRCV
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VRCV beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRCV + JNJ for your $10,000?

VRCV: 50%JNJ: 50%
100% JNJ50/50100% VRCV
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VRCV
No analyst data
Altman Z
-22.2
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRCV buys
0
JNJ buys
0
No recent congressional trades found for VRCV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRCVJNJ
Forward yield200000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.911780474428384e+29M$20.0K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.911464459982279e+29M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VRCV vs JNJ ($10,000, DRIP)

YearVRCV PortfolioVRCV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$20,010,700$20,000,000.00$10,676$355.77+$20.00M → VRCV
2$37,424,589,019$37,403,177,570.09$11,407$389.39+$37424.58M → VRCV
3$65,416,215,188,220$65,376,170,877,969.18$12,198$426.53+$65416215.18M → VRCV
4$106,868,230,495,008,900$106,798,235,144,757,520.00$13,056$467.62+$106868230495.00M → VRCV
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$13,987$513.12+$163172871735896.88M → VRCV
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$14,998$563.56+$232854599801468864.00M → VRCV
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$16,098$619.52+$310570858137017057280.00M → VRCV
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$17,295$681.69+$3.871481543016132e+23M → VRCV
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$18,599$750.82+$4.510617497632811e+26M → VRCV
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$20,022$827.78+$4.911780474428384e+29M → VRCV

VRCV vs JNJ: Complete Analysis 2026

VRCV — Stock

Varca Ventures, Inc., an exploration stage company, engages in the acquisition and exploration of mineral properties. It owns interest in the Idaho property that comprises 15 patented lode mining claims covering approximately 141.5 acres located in La Plata County, Colorado; and the Mayday property, which consists of 12 patented lode mining claims covering approximately 151 acres in La Plata County, Colorado. The company was founded in 2005 and is headquartered in Sarasota, Florida.

Full VRCV Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VRCV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRCV vs SCHDVRCV vs JEPIVRCV vs OVRCV vs KOVRCV vs MAINVRCV vs ABBVVRCV vs MRKVRCV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.